Skip to Main Content

Paper Details

TRIM63 is a sensitive and specific biomarker for MiT family aberration-associated renal cell carcinoma.
Mod Pathol
16
2021
-, MiT, MiT family, MiT family aberration, MiTF, MiTF-, MiTF-RCC, Microphthalmia-associated transcription, Microphthalmia-associated transcription factor, RBM10, RCC, RNAseq, TFE3, TFE3 or TFEB genes, TFEB, TFEB genes, TRIM63, TRIM63 RNA, TRIM63 mRNA, benign kidney, clear cell RCC, papillary RCC, renal cell carcinoma, renal tumor, tumor
Author NameAffiliation
Xuhong CaoMichigan Center for Translational Pathology
Daniel E SprattUniversity of Michigan Medical School ann arbor
Pedram ArganiJohns Hopkins University School of Medicine
Victor E ReuterMemorial Sloan Kettering Cancer Center
Arul M ChinnaiyanUniversity of Michigan Medical School ann arbor
Arul M ChinnaiyanHoward Hughes Medical Institute
Arul M ChinnaiyanUniversity of Michigan Medical School ann arbor
Arul M ChinnaiyanRogel Cancer Center
Arul M ChinnaiyanMichigan Center for Translational Pathology
Arul M ChinnaiyanUniversity of Michigan Medical School ann arbor
Arul M ChinnaiyanMichigan Center for Translational Pathology
Arul M ChinnaiyanRogel Cancer Center
Arul M ChinnaiyanUniversity of Michigan Medical School ann arbor
Arul M ChinnaiyanHoward Hughes Medical Institute
Saravana M DhanasekaranUniversity of Michigan Medical School ann arbor
Saravana M DhanasekaranMichigan Center for Translational Pathology
Rohit MehraUniversity of Michigan Medical School ann arbor
Rohit MehraMichigan Center for Translational Pathology
Rohit MehraRogel Cancer Center
  • 1 - 19

Datasets

Release 1.2